Log in to save to my catalogue

The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children:...

The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_919255a78c304d0e821d604d2006b31f

The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children: a multicenter, randomized, double-blind, comparative, phase 3 clinical trial

About this item

Full title

The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children: a multicenter, randomized, double-blind, comparative, phase 3 clinical trial

Publisher

England: BioMed Central Ltd

Journal title

BMC pediatrics, 2018-06, Vol.18 (1), p.201-201, Article 201

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

We aimed to compare the antipyretic efficacy, safety, and tolerability between oral dexibuprofen and intravenous propacetamol in children with upper respiratory tract infection (URTI) presenting with fever.
Patients aging from 6 months to 14 years admitted for URTI with axillary body temperature ≥ 38.0 °C were enrolled and randomized into the st...

Alternative Titles

Full title

The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children: a multicenter, randomized, double-blind, comparative, phase 3 clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_919255a78c304d0e821d604d2006b31f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_919255a78c304d0e821d604d2006b31f

Other Identifiers

ISSN

1471-2431

E-ISSN

1471-2431

DOI

10.1186/s12887-018-1166-z

How to access this item